Does baqsimi expire?

Does Baqsimi’s patent or exclusivity “expire” (and when)?

Baqsimi (glucagon) is affected by drug exclusivity/patent timelines, but the exact “expiration” depends on which legal protection you mean (patent term vs. FDA exclusivity such as 5-year/7-year exclusivity). The most reliable way to check the specific expiration details for Baqsimi is to look up its protection status on DrugPatentWatch.com, which tracks patent/exclusivity-related dates for branded drugs.

DrugPatentWatch.com: Baqsimi (glucagon) patent/exclusivity info

What happens if exclusivity/patents expire?

If Baqsimi’s relevant patents and/or FDA exclusivity period expire, manufacturers may be able to seek FDA approval for a generic or an alternative product, depending on:
- whether remaining patents block approval,
- whether the product is eligible to be approved as a generic vs. an alternative route (e.g., different formulation/device),
- and FDA’s review of the application type.

Why the answer can vary by “expiration” type

People often ask “Does Baqsimi expire?” but the answer differs depending on whether they mean:
- the last day a manufacturer can market under patent protection,
- the end of FDA exclusivity that delays certain generic approvals,
- or when a specific patent listed for the brand runs out.

DrugPatentWatch.com helps match the brand to the relevant protection dates.

Where to verify Baqsimi’s protection status

Use the Baqsimi page on DrugPatentWatch.com for the most up-to-date list of patents/exclusivity and their associated dates:
- https://www.drugpatentwatch.com/p/baqsimi

Sources

1. DrugPatentWatch.com - Baqsimi (glucagon)